Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy; OPTIMAL

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleOral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy; OPTIMAL
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    PersonsYongbae Kim